Immunoassay Market By Product, By Technology By Specimen By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Immunoassay Market

The immunoassay market was valued at $35.0 billion in 2023 and is projected to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.

Immunoassay is a bioanalytical method that detects and quantifies the presence of proteins or antigens in a sample. The basic principle of immunoassay relies on the interaction between an antibody and a target molecule, which results in the generation of a quantifiable signal, such as fluorescence or color change. The method finds applications in pharmaceutical research, medical diagnostics, and environmental monitoring. The high specificity & sensitivity of the method is pivotal in monitoring drug levels, diagnosing diseases, screening for infectious agents, and detecting biomarkers.

Rise in the prevalence of infectious and chronic diseases is a significant driver of the immunoassay market. In addition, surge in investments in the pharmaceutical & biotechnology infrastructure has led to the expansion in infrastructure, thereby boosting the demand for immunoassay components for diverse purposes such as clinical trials, biomarker analysis, and drug discovery. Trends in the immunoassay market evolve constantly, enhancing the sensitivity and specificity of the tests. The integration of robotics and automation is acquiring traction in the market as it is enhancing productivity and helping to reduce human error in the laboratories.

However, procuring reliable instruments and authentic samples to critical for obtaining successful results. The acquisition of such trustworthy components is a challenging task owing to less retailers in the industry, thereby restraining the development of the immunoassay market. On the contrary, manufacturers of immunoassay systems strive to introduce innovative products, thereby presenting lucrative opportunities for market development. Next generation of immunoassay systems is projected to leverage the benefits of microfluidics and nanotechnology for achieving instant & accurate results.

Segment Review

The immunoassay market is segmented into product, technology, specimen, end user, and region. On the basis of product, the market is bifurcated into reagents & kits and analyzers. As per technology, it is classified into ELISA, chemiluminescence immunoassay, immunofluorescence assay, rapid test, ELISpot, western blotting, and others. According to specimen, it is categorized into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, and others. By end user, it is divided into hospitals & clinics, clinical laboratories, pharmaceutical & biotechnology companies, blood banks, research & academic laboratories, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

As per technology, the ELISA segment generated the highest revenue in 2023.

According to specimen, the blood screening segment was the highest shareholder in 2023.

By end user, the hospitals & clinics segment acquired high market stakes in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global immunoassay market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Siemens Healthineers, DiaSorin S.p.A., Sysmex Corporation, BioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Merck kGaA. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data

Key Market Segments

By Product

Reagents and Kits
Analyzers

By Technology

ELISA
Chemiluminescence Immunoassay
Immunofluorescence assay
Rapid Test
ELISpot
Western Blotting
Others

By Specimen

Infectious Diseases
Endocrinology
Oncology
Bone and Mineral Disorders
Cardiology
Blood Screening
Autoimmune Disorders
Allergy Diagnostics
Toxicology
Newborn Screening
Others

By End User

Hospitals and Clinics
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Blood Banks
Research and Academic Laboratories
Home Care Settings

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

F. Hoffmann-La Roche Ltd.
Danaher Corporation
Abbott Laboratories
Siemens Healthineers
DiaSorin S.p.A.
Sysmex Corporation
BioMerieux SA
Ortho Clinical Diagnostics
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Merck kGaA

Product Code: A00792

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: IMMUNOASSAY MARKET, BY PRODUCT

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
4.2. Reagents And Kits
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Analyzers
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNOASSAY MARKET, BY TECHNOLOGY

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Technology
5.2. ELISA
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Chemiluminescence Immunoassay
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Immunofluorescence Assay
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Rapid Test
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
5.6. ELISpot
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
5.7. Western Blotting
- 5.7.1. Key Market Trends, Growth Factors and Opportunities
- 5.7.2. Market Size and Forecast, By Region
- 5.7.3. Market Share Analysis, By Country
5.8. Others
- 5.8.1. Key Market Trends, Growth Factors and Opportunities
- 5.8.2. Market Size and Forecast, By Region
- 5.8.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNOASSAY MARKET, BY SPECIMEN

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Specimen
6.2. Infectious Diseases
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Endocrinology
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Oncology
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
6.5. Bone And Mineral Disorders
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
6.6. Cardiology
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
6.7. Blood Screening
- 6.7.1. Key Market Trends, Growth Factors and Opportunities
- 6.7.2. Market Size and Forecast, By Region
- 6.7.3. Market Share Analysis, By Country
6.8. Autoimmune Disorders
- 6.8.1. Key Market Trends, Growth Factors and Opportunities
- 6.8.2. Market Size and Forecast, By Region
- 6.8.3. Market Share Analysis, By Country
6.9. Allergy Diagnostics
- 6.9.1. Key Market Trends, Growth Factors and Opportunities
- 6.9.2. Market Size and Forecast, By Region
- 6.9.3. Market Share Analysis, By Country
6.10. Toxicology
- 6.10.1. Key Market Trends, Growth Factors and Opportunities
- 6.10.2. Market Size and Forecast, By Region
- 6.10.3. Market Share Analysis, By Country
6.11. Newborn Screening
- 6.11.1. Key Market Trends, Growth Factors and Opportunities
- 6.11.2. Market Size and Forecast, By Region
- 6.11.3. Market Share Analysis, By Country
6.12. Others
- 6.12.1. Key Market Trends, Growth Factors and Opportunities
- 6.12.2. Market Size and Forecast, By Region
- 6.12.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNOASSAY MARKET, BY END USER

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End User
7.2. Hospitals And Clinics
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
7.3. Clinical Laboratories
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
7.4. Pharmaceutical And Biotechnology Companies
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
7.5. Blood Banks
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country
7.6. Research And Academic Laboratories
- 7.6.1. Key Market Trends, Growth Factors and Opportunities
- 7.6.2. Market Size and Forecast, By Region
- 7.6.3. Market Share Analysis, By Country
7.7. Home Care Settings
- 7.7.1. Key Market Trends, Growth Factors and Opportunities
- 7.7.2. Market Size and Forecast, By Region
- 7.7.3. Market Share Analysis, By Country

CHAPTER 8: IMMUNOASSAY MARKET, BY REGION

8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product
- 8.2.3. Market Size and Forecast, By Technology
- 8.2.4. Market Size and Forecast, By Specimen
- 8.2.5. Market Size and Forecast, By End User
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Immunoassay Market
  - 8.2.7.1. Market Size and Forecast, By Product
  - 8.2.7.2. Market Size and Forecast, By Technology
  - 8.2.7.3. Market Size and Forecast, By Specimen
  - 8.2.7.4. Market Size and Forecast, By End User
- 8.2.8. Canada Immunoassay Market
  - 8.2.8.1. Market Size and Forecast, By Product
  - 8.2.8.2. Market Size and Forecast, By Technology
  - 8.2.8.3. Market Size and Forecast, By Specimen
  - 8.2.8.4. Market Size and Forecast, By End User
- 8.2.9. Mexico Immunoassay Market
  - 8.2.9.1. Market Size and Forecast, By Product
  - 8.2.9.2. Market Size and Forecast, By Technology
  - 8.2.9.3. Market Size and Forecast, By Specimen
  - 8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product
- 8.3.3. Market Size and Forecast, By Technology
- 8.3.4. Market Size and Forecast, By Specimen
- 8.3.5. Market Size and Forecast, By End User
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. France Immunoassay Market
  - 8.3.7.1. Market Size and Forecast, By Product
  - 8.3.7.2. Market Size and Forecast, By Technology
  - 8.3.7.3. Market Size and Forecast, By Specimen
  - 8.3.7.4. Market Size and Forecast, By End User
- 8.3.8. Germany Immunoassay Market
  - 8.3.8.1. Market Size and Forecast, By Product
  - 8.3.8.2. Market Size and Forecast, By Technology
  - 8.3.8.3. Market Size and Forecast, By Specimen
  - 8.3.8.4. Market Size and Forecast, By End User
- 8.3.9. Italy Immunoassay Market
  - 8.3.9.1. Market Size and Forecast, By Product
  - 8.3.9.2. Market Size and Forecast, By Technology
  - 8.3.9.3. Market Size and Forecast, By Specimen
  - 8.3.9.4. Market Size and Forecast, By End User
- 8.3.10. Spain Immunoassay Market
  - 8.3.10.1. Market Size and Forecast, By Product
  - 8.3.10.2. Market Size and Forecast, By Technology
  - 8.3.10.3. Market Size and Forecast, By Specimen
  - 8.3.10.4. Market Size and Forecast, By End User
- 8.3.11. UK Immunoassay Market
  - 8.3.11.1. Market Size and Forecast, By Product
  - 8.3.11.2. Market Size and Forecast, By Technology
  - 8.3.11.3. Market Size and Forecast, By Specimen
  - 8.3.11.4. Market Size and Forecast, By End User
- 8.3.12. Rest of Europe Immunoassay Market
  - 8.3.12.1. Market Size and Forecast, By Product
  - 8.3.12.2. Market Size and Forecast, By Technology
  - 8.3.12.3. Market Size and Forecast, By Specimen
  - 8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product
- 8.4.3. Market Size and Forecast, By Technology
- 8.4.4. Market Size and Forecast, By Specimen
- 8.4.5. Market Size and Forecast, By End User
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. China Immunoassay Market
  - 8.4.7.1. Market Size and Forecast, By Product
  - 8.4.7.2. Market Size and Forecast, By Technology
  - 8.4.7.3. Market Size and Forecast, By Specimen
  - 8.4.7.4. Market Size and Forecast, By End User
- 8.4.8. Japan Immunoassay Market
  - 8.4.8.1. Market Size and Forecast, By Product
  - 8.4.8.2. Market Size and Forecast, By Technology
  - 8.4.8.3. Market Size and Forecast, By Specimen
  - 8.4.8.4. Market Size and Forecast, By End User
- 8.4.9. India Immunoassay Market
  - 8.4.9.1. Market Size and Forecast, By Product
  - 8.4.9.2. Market Size and Forecast, By Technology
  - 8.4.9.3. Market Size and Forecast, By Specimen
  - 8.4.9.4. Market Size and Forecast, By End User
- 8.4.10. South Korea Immunoassay Market
  - 8.4.10.1. Market Size and Forecast, By Product
  - 8.4.10.2. Market Size and Forecast, By Technology
  - 8.4.10.3. Market Size and Forecast, By Specimen
  - 8.4.10.4. Market Size and Forecast, By End User
- 8.4.11. Australia Immunoassay Market
  - 8.4.11.1. Market Size and Forecast, By Product
  - 8.4.11.2. Market Size and Forecast, By Technology
  - 8.4.11.3. Market Size and Forecast, By Specimen
  - 8.4.11.4. Market Size and Forecast, By End User
- 8.4.12. Rest of Asia-Pacific Immunoassay Market
  - 8.4.12.1. Market Size and Forecast, By Product
  - 8.4.12.2. Market Size and Forecast, By Technology
  - 8.4.12.3. Market Size and Forecast, By Specimen
  - 8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product
- 8.5.3. Market Size and Forecast, By Technology
- 8.5.4. Market Size and Forecast, By Specimen
- 8.5.5. Market Size and Forecast, By End User
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Immunoassay Market
  - 8.5.7.1. Market Size and Forecast, By Product
  - 8.5.7.2. Market Size and Forecast, By Technology
  - 8.5.7.3. Market Size and Forecast, By Specimen
  - 8.5.7.4. Market Size and Forecast, By End User
- 8.5.8. South Africa Immunoassay Market
  - 8.5.8.1. Market Size and Forecast, By Product
  - 8.5.8.2. Market Size and Forecast, By Technology
  - 8.5.8.3. Market Size and Forecast, By Specimen
  - 8.5.8.4. Market Size and Forecast, By End User
- 8.5.9. Saudi Arabia Immunoassay Market
  - 8.5.9.1. Market Size and Forecast, By Product
  - 8.5.9.2. Market Size and Forecast, By Technology
  - 8.5.9.3. Market Size and Forecast, By Specimen
  - 8.5.9.4. Market Size and Forecast, By End User
- 8.5.10. Rest of LAMEA Immunoassay Market
  - 8.5.10.1. Market Size and Forecast, By Product
  - 8.5.10.2. Market Size and Forecast, By Technology
  - 8.5.10.3. Market Size and Forecast, By Specimen
  - 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

10.1. F. Hoffmann-La Roche Ltd.
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
10.2. Danaher Corporation
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
10.3. Abbott Laboratories
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
10.4. Siemens Healthineers
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
10.5. DiaSorin S.p.A.
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
10.6. Sysmex Corporation
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
10.7. BioMerieux SA
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
10.8. Ortho Clinical Diagnostics
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
10.9. Thermo Fisher Scientific, Inc.
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
10.10. Becton, Dickinson And Company
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments
10.11. Merck KGaA
- 10.11.1. Company Overview
- 10.11.2. Key Executives
- 10.11.3. Company Snapshot
- 10.11.4. Operating Business Segments
- 10.11.5. Product Portfolio
- 10.11.6. Business Performance
- 10.11.7. Key Strategic Moves and Developments